SCHEMBL6173698

SCHEMBL6173698

CC(c1ccncc1Cl)C1NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
NPBWR1 P48145 2/20 0.40
MCHR1 Q99705 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.38
POLB P06746 1/20 0.38
CCR9 P51686 1/20 0.35
CXCR3 P49682 1/20 0.34
CYP3A4 P08684 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
KDM4C Q9H3R0 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA3 P34903 1/20 0.32
JAK2 O60674 1/20 0.32
LIPE Q05469 4/20 0.32
PDE2A O00408 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172100 0.87 LMNA (0.38) LMNANPBWR1MCHR1L3MBTL1POLB
SCHEMBL6173186 0.86 LMNA (0.40) LMNANPBWR1MCHR1L3MBTL1POLB
SCHEMBL6172442 0.85 LMNA (0.40) LMNANPBWR1MCHR1L3MBTL1POLB
SCHEMBL6170501 0.85 LMNA (0.42) LMNAL3MBTL1POLBCXCR3KDM4C
SCHEMBL6172197 0.85 LMNA (0.40) LMNANPBWR1MCHR1L3MBTL1POLB
SCHEMBL6176359 0.85 LMNA (0.39) LMNANPBWR1MCHR1L3MBTL1POLB
SCHEMBL6177656 0.84 LMNA (0.37) LMNAL3MBTL1POLBCYP3A4
SCHEMBL6170777 0.84 LMNA (0.38) LMNANPBWR1MCHR1L3MBTL1POLB
SCHEMBL6176406 0.84 LMNA (0.39) LMNAL3MBTL1POLBCXCR3CYP3A4
SCHEMBL6174750 0.84 LMNA (0.39) LMNANPBWR1MCHR1L3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed